Sign In
Buy MDAI
$1.94
-0.120 (-5.83%)
At Close: Jun 03, 2026
DALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster
Spectral AI to Participate in Upcoming Investor Conferences
04:30pm, Wednesday, 28'th Aug 2024
DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI completes burn center enrollment early for pivotal study
09:14am, Tuesday, 27'th Aug 2024
Spectral AI Inc (NASDAQ:MDAI) announced that it has completed the enrollment of adult and pediatric patients at US burn centers for its pivotal study designed to validate the AI algorithm used by its
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
08:00am, Tuesday, 27'th Aug 2024
Milestone Achievement Advances Commercialization Timeline for DeepView™ System for Burn Indication Milestone Achievement Advances Commercialization Timeline for DeepView™ System for Burn Indicatio
Spectral AI to present data from ongoing pivotal burn study at conference
10:02am, Monday, 19'th Aug 2024
Spectral AI Inc (NASDAQ:MDAI) announced that its chief medical consultant Dr Jeffrey Carter will present data from its ongoing multicenter study evaluating its DeepView System for burns at an upcomin
DALLAS, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI, Inc. (MDAI) Q2 2024 Earnings Call Transcript
08:32pm, Monday, 12'th Aug 2024
Spectral AI, Inc. (NASDAQ:MDAI ) Q2 2024 Results Conference Call August 12, 2024 5:00 PM ET Company Participants Devin Sullivan - Managing Director, The Equity Group, Inc. Peter Carlson - Chief Execut
Spectral AI grows revenue, advances DeepView System for burns in Q2
04:48pm, Monday, 12'th Aug 2024
Spectral AI Inc (NASDAQ:MDAI) reported a 76% year-over-year jump in revenue for the second quarter as it advanced its AI-driven DeepView System for the burn indication. The company said its Q2 researc
Spectral AI Announces 2024 Second Quarter Financial Results
04:05pm, Monday, 12'th Aug 2024
Second Quarter Revenue Totals $7.5 Million Total Enrollment Exceeds 85% for Burn Center Pivotal U.S. Clinical Trial Q2 2024 Overview Research & Development Revenue of $7.5 Million Cash Position of $6.
Spectral AI advances handheld burn assessment device for military use
09:03am, Wednesday, 31'st Jul 2024
Spectral AI Inc (NASDAQ:MDAI) announced it continues to advance the development of the DeepView SnapShot M, a handheld diagnostic tool for battlefield burn assessments leveraging its AI-driven DeepVie
Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
08:00am, Wednesday, 31'st Jul 2024
Poster Presentation at 2024 Military Health System Research Symposium Poster Presentation at 2024 Military Health System Research Symposium
Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call
09:00am, Monday, 29'th Jul 2024
DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI expands patent portfolio, bolstering AI-driven wound care platform
10:02am, Wednesday, 24'th Jul 2024
Spectral AI Inc (NASDAQ:MDAI) announced a 30% increase in its patent portfolio, enhancing the protection of its proprietary DeepView System wound assessment platform. The total number of patents grant
DALLAS, July 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI adds three new clinical sites to pivotal burn study
09:44am, Tuesday, 23'rd Jul 2024
Spectral AI Inc (NASDAQ:MDAI) announced it has added three new US trial sites to its 2024 Burn Pivotal Study, bringing the total number of sites, including burn centers and emergency departments, to
